Clinical and Translational Radiation Oncology
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 3.6 | Q1 | 77.0% | 1.248 | Q1 | 88.8% |
| 2024 | 2.7 | Q2 | 67.3% | 0.886 | Q1 | 81.0% |
| 2023 | 2.7 | Q2 | 66.5% | 0.999 | Q1 | 85.5% |
| 2022 | 3.1 | Q2 | 68.3% | 1.104 | Q1 | 88.3% |
| 2021 | 4.7 | Q2 | 80.8% | 1.363 | Q1 | 91.8% |
| 2020 | — | — | 1.336 | Q1 | 90.8% | |
| 2019 | — | — | 1.297 | Q1 | 90.5% | |
| 2018 | — | — | — | 0.0% | ||
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
ISSN
2405-6308
country
IEcoverage
2016-2026